Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeHealth

      Health

      An Analysis of pSivida Corp.
      Drugs

      An Analysis of pSivida Corp.

      October 2, 2017
      pSivida Announces Development of Sustained Release Glaucoma Drug with a Partner Global Pharmaceuticals Company
      Drug Manufacturers

      pSivida Announces Development of Sustained Release Glaucoma Drug with a Partner Global Pharmaceuticals Company

      September 29, 2017
      pSivida Corp.: What the Indicators Tell Us
      Health

      pSivida Corp.: What the Indicators Tell Us

      September 28, 2017
      Quarterly Returns Drop by -20.07% for Organovo Holdings, Inc.
      Health

      Quarterly Returns Drop by -20.07% for Organovo Holdings, Inc.

      September 28, 2017
      Community Health Systems Sees Thin Trading Volume
      Health

      Community Health Systems Sees Thin Trading Volume

      September 27, 2017
      What Can We Learn About Community Health Systems, Inc from Insider Trends?
      Health

      What Can We Learn About Community Health Systems, Inc from Insider Trends?

      September 26, 2017
      What are Analysts Saying About Community Health Systems?
      Health

      What are Analysts Saying About Community Health Systems?

      September 26, 2017
      Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating
      Healthcare

      Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating

      September 26, 2017
      Forecasts Predict $40.82 Million in Sales from OraSure Technologies, Inc.
      Health

      Forecasts Predict $40.82 Million in Sales from OraSure Technologies, Inc.

      September 26, 2017
      Stock Rating for OraSure Technologies, Inc. lowered by Zacks Investment Research
      Health

      Stock Rating for OraSure Technologies, Inc. lowered by Zacks Investment Research

      September 25, 2017
      « 1 … 203 204 205 206 207 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026